Vidipha Central Pharmaceutical JSC (HOSE:VDP)

Vietnam · Delayed Price · Currency is VND

53,100

-3,900 (-6.84%)

At close: Jul 2, 2026

43.51% (1Y)

Market Cap	1.17T +55.3%
Revenue (ttm)	971.25B +4.3%
Net Income	61.59B -11.2%
EPS	2,788.97
Shares Out	22.08M
PE Ratio	19.04
Forward PE	n/a
Dividend	2,500.00 (4.71%)
Ex-Dividend Date	n/a

Volume	101
Open	53,100
Previous Close	57,000
Day's Range	53,100 - 53,100
52-Week Range	36,000 - 60,500
Beta	-0.17
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 17, 2026

About HOSE:VDP

Vidipha Central Pharmaceutical Joint Stock Company produces and sells pharmaceutical products in Vietnam. It offers analgesics, antipyretics, gastrointestinal agents, antidiabetic agents, antibiotics, antivirals, antifungals, antihistamines, anti-allergic agents, respiratory agents, cardiovascular, neurological, antihypertensive agents, diuretics, vitamins, minerals, antiseptics, and others. The company also engages in the hotel and real estate businesses; and provision of drug storage and testing, and technology transfer consulting services. I... [Read more]

Industry Pharmaceutical Preparations

Founded 2003

Employees 469

Stock Exchange Ho Chi Minh Stock Exchange

Ticker Symbol VDP

Full Company Profile

Financial Performance

In 2025, HOSE:VDP's revenue was 985.64 billion, an increase of 5.47% compared to the previous year's 934.49 billion. Earnings were 63.81 billion, a decrease of -11.16%.

Financial Statements